Matthew Perrone, Author at Concord Monitor

Concord Monitor

The Concord Monitor is a Pulitzer Prize winning daily newspaper and website located in the capital city of New Hampshire. The Concord Monitor is Central NH's dominant media with more than 70 percent household penetration. The Monitor is a key source of news and information for Concord, NH.

Subscribe

FILE - Attendees practice administering Narcan during an overdose education and Narcan training class at the Onala Recovery Center on the South Shore of Pittsburgh on Monday, Dec. 13, 2021. U.S. health advisers are weighing whether the overdose-reversal drug, Narcan, should be made available as an over-the-counter medication to help fight the national opioid crisis. A panel of experts to the Food and Drug Administration will vote on the switch late Wednesday, Feb. 15, 2023...

Panel backs moving Narcan over-the-counter

by Matthew Perrone AP Health WriterFebruary 18, 2023

WASHINGTON — The overdose-reversing drug naloxone should be made available over the counter to aid the national response to the opioid crisis, U.S. health advisers said Wednesday.The expert panel to the Food and Drug Administration voted unanimously…

FILE - Packaging for an electronic cigarette and menthol pods from Juul Labs is displayed on Feb. 25, 2020, in Pembroke Pines, Fla. In a deal announced Tuesday, Sept. 6, 2022, electronic cigarette maker Juul Labs will pay nearly 440 million to settle a two-year investigation by 33 states into the marketing of its high-nicotine vaping products, which have long been blamed for sparking a national surge in teen vaping. (AP Photo/Brynn Anderson, File)

News

NH gets $8.5 million for Juul settlement

by Matthew Perrone Associated Press, and Dave Collins Associated PressSeptember 6, 2022

FILE - A one-month dosage of hormonal birth control pills is displayed in Sacramento, Calif., Aug. 26, 2016. A drug company is seeking U.S. approval for the first-ever birth control pill that women could buy without a prescription. The request from a French drugmaker sets up a high-stakes decision for the Food and Drug Administration amid the political fallout from the Supreme Court's recent decision overturning Roe v. Wade. (AP Photo/Rich Pedroncelli, File)

News

Over-the-counter birth control? Drugmaker seeks FDA approval

by Matthew Perrone AP Health WriterJuly 11, 2022

President Joe Biden speaks in the Rose Garden of the White House in Washington, Friday, May 13, 2022, during an event to highlight state and local leaders who are investing American Rescue Plan funding. (AP Photo/Andrew Harnik)

News

White House says deal near to reopen formula plant

by Zeke Miller Associated Press, and Matthew Perrone Associated PressMay 16, 2022

FILE - A syringe is prepared with the Pfizer COVID-19 vaccine at a clinic at the Reading Area Community College in Reading, Pa., on Sept. 14, 2021. U.S. regulators have opened up COVID-19 booster shots to all and more adults, Friday, Nov. 19, letting them choose another dose of either the Pfizer or Moderna vaccine. (AP Photo/Matt Rourke, File)

News

US expands COVID boosters to all adults, final hurdle ahead

by Lauran Neergaard Associated Press, and Matthew Perrone Associated PressNovember 19, 2021

A licensed practical nurse draws a Moderna COVID-19 vaccine into a syringe at a mass vaccination clinic at Gillette Stadium in Foxborough, Mass., on May 19. Starting Thursday, the FDA convenes its independent advisers for the first stage in the process of deciding whether extra shots of Moderna or J&J vaccines should be dispensed.

News

Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines

by Lauran Neergaard Associated Press, and Matthew Perrone Associated PressOctober 12, 2021

A patient with COVID-19 on breathing support lies in a bed in an intensive care unit of a Shreveport, La., hospital last month.

News

COVID-19 surge in the US: The summer of hope ends in gloom

by Matthew Perrone Associated Press, and Dee-Ann Durbin Associated PressSeptember 8, 2021

FILE - In this March 2, 2021, file photo, pharmacy technician Hollie Maloney loads a syringe with Pfizer's COVID-19 vaccine at the Portland Expo in Portland, Maine. The U.S. gave full approval to Pfizer's COVID-19 vaccine on Monday, Aug. 23, 2021. (AP Photo/Robert F. Bukaty, File)

News

US regulators give full approval to Pfizer COVID-19 vaccine

by Lauran Neergaard Associated Press, and Matthew Perrone Associated PressAugust 25, 2021

FILE - In this Jan. 25, 2021, file photo, a person wearing face mask as a precaution against the coronavirus walks near a sign advertising a rapid COVID-19 testing site in Philadelphia. U.S. healthy officials say that most fully vaccinated Americans can skip testing for COVID-19, even if they were exposed to someone infected. (AP Photo/Matt Rourke, File)

News

COVID testing’s value shrinks as vaccines beat back virus

by Matthew Perrone Associated PressMay 23, 2021

FILE - This Dec. 10, 2020 file photo shows Food and Drug Administration building in Silver Spring, Md. Each year the U.S. approves dozens of new uses for cancer drugs based on early signs that they can shrink or slow the spread of tumors. But how often do patients actually live longer, more active lives? That seemingly simple question is, in fact, one of the thorniest debates in medicine. (AP Photo/Manuel Balce Ceneta)

News

FDA to scrutinize unproven cancer drugs after 10-year gap

by Matthew Perrone Associated PressApril 25, 2021